According to Chen et al. (2017), curcumin have positive effects upon triple negative breast cancer mouse models through the inhibition of tumor growth, significantly reduced levels of CD44+/CD133− stem cells, the inhibition of β-catenin and androgen receptor in nuclei, and the decreased expression of ALDH1 [205,206]. This evidence concerns the gene CD44 and neoplasm.